Kurt Jenkins
Affiliations: | Beckman Research Institute of City of Hope, Monrovia, CA, United States |
Google:
"Kurt Jenkins"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jenkins KA, Park M, Pederzoli-Ribeil M, et al. (2023) XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer. Journal For Immunotherapy of Cancer. 11 |
Patel E, Malkova NV, Crowe D, et al. (2023) XTX301, a tumor-activated Interleukin-12 has the potential to widen the therapeutic index of IL-12 treatment for solid tumors as evidenced by pre-clinical studies. Molecular Cancer Therapeutics |
Kuo YC, Kuo CF, Jenkins K, et al. (2022) Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells. Journal For Immunotherapy of Cancer. 10 |
Karow M, Jenkins K, Park M, et al. (2018) Pre-clinical assessment of rational design immuno-oncology biologics with improved therapeutic indices. Journal of Clinical Oncology. 36 |
Herrmann A, Lahtz C, Nagao T, et al. (2017) CTLA4 promotes Tyk2-STAT3 dependent B cell oncogenecity. Cancer Research |